Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

60.73
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
54.98
Today|||52-Week Range
135.59
-44.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues13.8M21.0M30.9M41.3M
 
 
 
 
 
Cost of Goods Sold--97.0K279.0K172.0K
 
 
 
 
Depreciation And Amortization1.6M802.0K1.1M1.4M
 
 
 
 
 
 
Operating ExpensesGross Income--20.1M29.5M39.8M
 
 
 
 
General Expenses126.2M104.1M110.0M106.0M
 
 
 
 
 
Research And Development53.8M43.8M44.2M46.0M
 
 
 
 
 
Total Operating Expenses127.8M105.0M111.4M107.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-114.0M-84.0M-80.5M-66.2M
 
 
 
 
 
Interest Expense On Debt7.1M7.2M7.3M7.4M
 
 
 
 
 
Other Expenses1.1M1.2M1.2M924.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-120.0M-89.9M-86.6M-72.6M
 
 
 
 
 
Net Income-120.0M-89.9M-86.6M-72.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.8M24.9M25.0M25.1M
 
 
 
 
 
Shares To Calculate EPS Diluted24.8M24.9M25.0M25.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.84-$3.61-$3.46-$2.89
 
 
 
 
 
EPS Diluted-$4.84-$3.61-$3.46-$2.89